72. 下垂体性ADH分泌異常症 Pituitary ADH secretion disorder Clinical trials / Disease details

臨床試験数 : 41 / 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-007941-10-BE (EUCTR)	10/09/2008	02/07/2008	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		France;Hungary;Belgium;Germany
2	EUCTR2007-007941-10-HU (EUCTR)	04/08/2008	12/06/2008		A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 9.1;Level: LLT;Classification cod ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		Hungary;Germany;Belgium;France
3	NCT00728091 (ClinicalTrials.gov)	July 2008	31/7/2008	A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With D ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Hyponatremia;Inappropriate ADH Syndrome	Drug: satavaptan (SR121463);Drug: placebo	Sanofi	NULL	Terminated	18 Years	N/A	Both	2	Phase 3	United States
4	EUCTR2007-007941-10-FR (EUCTR)	16/06/2008	15/04/2008	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129	Phase 3	France;Hungary;Belgium;Germany
5	EUCTR2007-007941-10-DE (EUCTR)	11/06/2008	02/04/2008		A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		Hungary;Germany;Belgium;France
6	EUCTR2004-003985-14-DK (EUCTR)	19/09/2005	05/07/2005	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopre ...	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopre ...	Dilutional hyponatremia excluding chronic syndrome of inappropriate antidiuretic hormone secretion ( ...	Product Name: NA Product Code: SR121463B INN or Proposed INN: NA Product Name: NA Product Code: SR121463 ...	sanofi-aventis recherche & développement	NULL	Not Recruiting			Female: yes Male: yes	108		Hungary;Denmark;Sweden
7	EUCTR2004-005239-25-DE (EUCTR)	30/08/2005	16/06/2005	An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463Bin patient ...	An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463Bin patient ...	Syndrome of Inappropriate Antidiuretic Hormone (SIADH) with serum sodium between 115 and 132 mmol/L. ...	Product Name: NA Product Code: SR121463B INN or Proposed INN: NA Product Name: NA Product Code: SR121463 ...	Sanofi-Synthelabo Research	NULL	Not Recruiting			Female: yes Male: yes	55		Hungary;Germany;Spain
8	EUCTR2004-003985-14-SE (EUCTR)	24/08/2005	20/06/2005	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopre ...	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopre ...	Dilutional hyponatremia excluding chronic syndrome of inappropriate antidiuretic hormone secretion ( ...	Product Name: NA Product Code: SR121463B INN or Proposed INN: NA Product Name: NA Product Code: SR121463 ...	sanofi-aventis recherche & développement	NULL	Not Recruiting			Female: yes Male: yes	108		Hungary;Denmark;Sweden
9	EUCTR2004-005239-25-HU (EUCTR)	06/07/2005	11/05/2005	An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463Bin patient ...	An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463Bin patient ...	Syndrome of Inappropriate Antidiuretic Hormone (SIADH) with serum sodium between 115 and 132 mmol/L. ...	Product Name: NA Product Code: SR121463B INN or Proposed INN: NA Product Name: NA Product Code: SR121463 ...	Sanofi-Synthelabo Research	NULL	Not Recruiting			Female: yes Male: yes	55		Hungary;Germany;Spain
10	NCT00264914 (ClinicalTrials.gov)	July 2005	12/12/2005	Safety and Efficacy of SR121463Bin Patients With Syndrome of Inappropriate Antidiuretic Hormone Secr ...	An Open-Label, Multicenter Study Evaluating the Long-Term Safety and Efficacy of SR121463Bin Patient ...	Inappropriate ADH Syndrome;Hyponatremia	Drug: SR121463B	Sanofi	NULL	Completed	18 Years	N/A	Both	57	Phase 3	United States;Australia;Belgium;Brazil;Canada;France;Germany;Hong Kong;Hungary;Russian Federation;Sw ...

First Previous1 2Next Last